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ABSTRACT
In radiation therapy using electron and photon beams the dosimetry chain
consists of several sequential phases starting by the realization of the dose
quantity in the Primary Standard Dosimetry Laboratory and ending to the
calculation of the dose to a patient. A similar procedure can be described for
the dosimetry of epithermal neutron beams in boron neutron capture
therapy (BNCT). To achieve the required accuracy of the dose delivered to a
patient the quality of all steps in the dosimetry procedure has to be
considered. This work is focused on two items in the dosimetry chains: the
determination of the dose in the reference conditions and the evaluation of
the accuracy of dose calculation methods. The issues investigated and
discussed in detail are:  a) the calibration methods of plane parallel
ionization chambers used in electron beam dosimetry, b) the specification of
the critical dosimetric parameter i.e. the ratio of stopping powers for water
to air, waterairS )/( r , in photon beams, c) the feasibility of the twin ionization
chamber technique for dosimetry in epithermal neutron beams applied to
BNCT and (d) the determination accuracy of the calculated dose
distributions in phantoms in electron, photon, and epithermal neutron
beams.
The results demonstrate that up to a 3% improvement in the consistency of
dose determinations in electron beams is achieved by the calibration of
plane parallel ionization chambers in high energy electron beams instead of
calibrations in 60Co gamma beams. In photon beam dosimetry waterairS )/( r  can
be determined with an accuracy of 0.2% using the percentage dose at the 10
cm depth, %dd(10), as a beam specifier. The use of  %dd(10) requires the
elimination of the electron contamination in the photon beam. By a twin
ionization chamber technique the gamma dose can be determined with
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uncertainty of 6% (1 standard deviation) and the total neutron dose with an
uncertainty of 15 to 20% (1 standard deviation). To improve the accuracy of
the twin ionization chamber technique in epithermal neutron beams,
improvements in chamber materials, and development of neutron beam
calibration facilities for chambers are required. The general accuracy
achieved by treatment planning systems is approximately 4% for photons
and 5 to 7% for electrons. Large (> 10%) deviations in calculated doses are
possible even when relatively modern calculation approaches are used. For
treatment planning systems used in BNCT, intercomparisons and similar
validation procedures as for treatment planning systems for electron and
photon beams should be performed.
STUK-A164
5
CONTENTS
ABSTRACT 3
LIST OF PUBLICATIONS 6
NOMENCLATURE 7
1 AIM OF THE STUDY 9
2 INTRODUCTION 10
3 QUALITY OF RADIOTHERAPY DOSIMETRY 14
3.1 Dosimetric accuracy requirements 14
3.2 Treatment and dosimetry procedures 15
3.3 Quality assurance of dosimetry 17
4 MEASUREMENT OF DOSE IN THE REFERENCE CONDITIONS 18
4.1 Calibration of ionization chambers 18
4.2 Specification of beam quality 21
5 CALCULATION OF DOSE TO A PATIENT 24
5.1 Treatment planning systems 24
5.2 Verification of calculated doses 26
6 DISCUSSION 28
6.1 Calibration of ionization chambers 28
6.2  Specification of photon beam quality 30
6.3 Verification of calculated doses 32
7  SUMMARY 36
ACKNOWLEDGEMETS 37
REFERENCES 39
PUBLICATIONS
STUK-A164
6
LIST OF PUBLICATIONS
This thesis is based on the following original publications, which are referred
to in the text by their Roman numerals, Publ.I-V.
I Kosunen A, Järvinen H. Application of Li2B4O7 TL detectors for
control of inhomogeneity calculations by radiotherapy treatment
planning systems. Radiat. Prot. Dosim. 1990; 34: 257–260.
II Kosunen A, Järvinen H, Vatnitskij S, Ermakov I, Chervjakov A,
Kulmala J, Pitkänen M, Väyrynen T, Väänänen A. Intercomparison
of radiotherapy treatment planning systems for external photon
and electron beam dose calculations, Radiother. Oncol. 1993; 29:
327–335.
III Kosunen A, Rogers DWO. Beam quality specification for photon
beam dosimetry, Med. Phys. 1993; 20: 1181–1188.
IV Kosunen A, Järvinen H, Sipilä P. Optimum calibration of NACP
type plane parallel ionization chambers for absorbed dose
determination in low energy electron beams, IAES-SM-330/41,
1994: 505–513.
V Kosunen A, Kortesniemi M, Ylä-Mella H, Seppälä T, Lampinen J,
Serén T, Auterinen I, Järvinen H, Savolainen S. Twin ionization
chambers for dose determinations in phantom in an epithermal
neutron beam, Radiat. Prot. Dosim. 1999; 81: 187–194.
STUK-A164
7
NOMENCLATURE
 AAPM American Association of Physicists in Medicine
 BNCT Boron Neutron Capture Therapy
 CoP Code of Practice
 CT Computed Tomography
 ESTRO European Society for Therapeutic Radiology and Oncology
 IAEA International Atomic Energy Agency
 IEC International Electrotechnical Commission
 IPEMP Institution of Physics and Engineering in Medicine and Biology
 ISO International Organization for Standardization
 J10/J20 Ratio of ionization at depth of 10 cm to that at depth of  20 cm
 LET Linear Energy Transfer
 MC Monte Carlo
 MRI Magnetic Resonance Imaging
 NACP Nordic Association of Clinical Physics
 PP Plane Parallel
 PSDL Primary Standard Dosimetry Laboratory
 QA Quality Assurance
 QC Quality Control
 SSDL Secondary Standard Dosimetry Laboratory
 TE Tissue Equivalent
 TLD Thermoluminescent dosimetry
20
10TPR Tissue-phantom-ratio. Ratio of doses at depths of 20 cm and 10
cm
 TPS Treatment Planning System
 WHO World Health Organization
 2D Two dimensional
 3D Three dimensional
 A150 Plastic substitute material for muscle tissue
C Factor for an ionization chamber to convert the calibration factor
in laboratory conditions to that in a user beam
TE
KnC , Factor for a TE ionization chamber to convert the air kerma cali-
bration factor in a 60Co gamma beam to that for neutron radiation
TE
KC ,g Factor for a TE ionization chamber to convert the air kerma cali-
bration factor in a 60Co gamma beam to that for photon radiation
nD Absorbed dose to a medium from neutron radiation
gD Absorbed dose to a medium from photon radiation
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 d(80%) Depth of the 80% dose level
0E Mean energy at phantom surface
ZE Mean energy in phantom at depth z
 g Fraction of energy of secondary charged particles that is lost to
bremsstrahlung in air in a 60Co gamma beam
1
2)(K  Ratio of kermas for medium 1 to medium 2
mk  Factor to take into account the non-air equivalence of the
chamber wall in air in a 60Co gamma beam
attk  Factor to take into account the attenuation and scatter of
photons in the wall of the chamber in a 60Co gamma beam
N Calibration factor for an ionization chamber
DN Absorbed dose -calibration factor for an ionization chamber
KN Air kerma -calibration factor for an ionization chamber
 p Factor to take into account the difference of the electron and
photon/neutron fluence in an ionization chamber and in a
phantom *
Q Electric charge
 R50 Half value depth for electrons
 Rp Practical range for electrons
wall
gasr  Gas-to-wall dose conversion factor
1
2)/( rS  Ratio of mass collision stopping powers for medium 1 to medium
2
W Energy required to produce an ion pair
%dd(10) Percentage depth dose at 10 cm
1
2)/( rm  Ratio of mass energy absorption coefficients for medium 1 to
medium 2
1sd One standard deviation
                                                
* Perturbation factor p can have a subscripts c or u depending on the beam considered i.e.
subscript c for calibration beam and subscript u for user beam. In Publ. IV symbol pu, pp is used for
perturpation factor both in calibration and user beams.
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1 AIM OF THE STUDY
The aim of this study is to analyse and improve the reliability of dosimetry
of electron and photon beams in external radiation therapy and neutron
beams in boron neutron capture therapy (BNCT). High energy electron and
photon beams and epithermal neutron beams are considered. The work is
focused on two items in the dosimetry chains: determination of the dose in
the reference conditions and evaluation of the accuracy of the dose
calculation methods.
The specific aims of the study are:
a) to investigate the effect of the calibration methods of the plane parallel
ionization chambers on the accuracy of dose measurements in electron
beams,
 
b) to establish a new radiation beam quality specifier for dosimetry of
photon beams,
 
c) to evaluate the feasibility of the twin ionization chamber method for
dose determinations in epithermal neutron beams applied to BNCT,
 
d) to study the accuracy of the calculated dose distributions in phantoms
in electron, photon and epithermal neutron beams.
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2 INTRODUCTION
Radiation therapy is a clinical modality dealing with the use of high doses of
ionizing radiations in the treatment of patients mostly having malignant
tumors. The aim of radiation therapy is to deliver a sufficiently high
absorbed dose to a defined target volume resulting in the eradication of the
tumor with as minimal a damage as possible to the surrounding healthy
tissues.
Radiotherapy with external high energy photon beams is the most common
radiotherapy modality [116]. Electron beams are used either as the primary
mode of radiation therapy or combined with photon beams. High energy
electron and photon beams are typically produced by linear accelerators and
also by microtrons [59, 107]. The traditional 60Co gamma units and betatron
electron accelerators are still in use in some radiotherapy centres. For a
typical multi-energy medical linear accelerator the accelerating potential
spans between 4 and 25 MV. The mean energy of the electron beams is
between 4 and 22 MeV and of photon beams between 1.5 and 7 MeV [59, 77].
In external beam therapy, to optimize the dose distribution in a patient the
dose is typically delivered from different directions by beams of modified
shape and intensity.
Boron Neutron Capture Therapy (BNCT) is a special radiation therapy
modality where the dose is targeted to the tumor cells by a pharmaceutical
containing the 10B-compound [9]. In the modern BNCT neutron beams the
mean energy of the spectrum is adjusted at the epithermal energy range
(from 0.5 eV to 10 keV), so that the final thermalisation of neutrons takes
place in the target tissue [32]. The potential sources for BNCT neutron
beams are nuclear reactors, proton accelerators and neutron emitting
isotopes. So far, only nuclear reactors have been used for neutron
production in BNCT treatments [32]. In BNCT the therapeutic dose is
produced by the high-LET particles released in a 10B(n,a)7Li reaction, as the
target area is exposed to thermal neutrons. Most of the unwanted radiation
in tissue is gamma radiation from the neutron capture of hydrogen where
2.23 MeV photons are emitted. Other significant components inducing dose
are the recoil protons of epithermal and fast neutrons from the neutron
capture of nitrogen [31].
The concept of dosimetry covers the determination of absorbed dose to a
medium both by measurement and by calculation. Dosimetry covers also the
two different aspects of radiation: the description of the radiation quality
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and the description of the energy deposited in a medium (the absorbed
dose) [57]. Metrology is a field of knowledge of measuring a value of a
physical quantity, including both the theoretical and the practical aspects of
measurement [53]. Measurement of absorbed dose of ionizing radiation is an
exceptional area in metrology as the accuracy achieved in measurements at
laboratory conditions is close to the accuracy required in typical
applications. The requirement of accuracy is most emphasized in
radiotherapy where the reference dose in a clinic should be measured with
the same level of accuracy as in a dosimetry laboratory [6, 16, 44,  74, 117].
To assure the consistency of dosimetry and the metrological traceability of
calibrations, the dosimetry procedures in radiation therapy are guided
internationally. For common radiotherapy modalities, such as external beam
therapy by high energy electrons and photons or by fast neutrons, the
guidance for dosimetry is established by organizations of metrology and
medical physics [18, 39, 47, 52, 80]. In these radiotherapy modalities the
improvements in the dosimetric methods and data come into effect only
after the improvements are implemented in the widely used dosimetry
reports and Codes of Practice (CoP) for dosimetry. For uncommon and
specific type of radiotherapy modalities, such as BNCT, no uniform
international guidance for dosimetry exists, so far. In BNCT the work
towards coherent dosimetry procedures was started in 1998, when a
European project for a CoP of epithermal neutron beams in BNCT was
launched  [111].
In dosimetry of radiation therapy the importance of quality assurance (QA)
has been emphasized since the establishment of systematic dosimetry
procedures [44, 79, 80, 81]. During the recent years interest in quality-
oriented systems has increased in the medical field. The American
Association of Physicists in Medicine (AAPM) has published
recommendations for a comprehensive QA for radiation therapy in 1994
and the European Society for Therapeutic Radiology and Oncology (ESTRO)
has presented a frame for a quality system based on the guidelines of the
International Standardization Organization (ISO) in 1997 [1, 30, 55]. In the
BNCT community the validity of quality-oriented treatment procedures has
been recognized [103] and the baselines for a dosimetry quality program has
been presented by Rassow et al. [95].
The experimental dosimetry of electron and photon beams is based on the
use of ionization chambers. Ionization chambers are also recommended as
reference dosemeters for mixed neutron and gamma beams of fast
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neutrons. In dosimetry of epithermal neutron beams various types of
dosemeters are required for dose characterization, because of the mixed
neutron and gamma radiation field and the spread of the neutron energy
and fluence. The twin ionization chamber technique has been applied for the
determination of neutron and gamma doses in epithermal neutron beams
for BNCT [93, 100].
The primary measurement standards at the Primary Standard Dosimetry
Laboratories (PSDL) and the dissemination of absorbed dose to users have
traditionally been based on physical quantities “in air”. The calibrations of
radiotherapy dosemeters have been, and mainly still are, performed for air
kerma in a 60Co gamma beam [10]. During this decade calibrations for
absorbed dose to water in PSDLs have become available and CoPs based on
the absorbed dose to water are under development [12, 99]. In PSDLs
calibrations for absorbed dose to water in other than 60Co gamma beams are
possible [10, 20]. According to the hierarchic system of metrological
laboratories the calibrations of user dosemeters are commonly performed in
Secondary Standard Dosimetry Laboratories (SSDL). To improve the
availability of SSDL services world-wide the International Atomic Energy
Agency (IAEA) and the World Health Organization (WHO) have established
a network of SSDLs [41]. SSDLs provide a direct linkage of national
dosimetry standards to the international measurement system and offer
calibration, training and quality audit services for radiation therapy clinics
[34, 39, 41]
The work is concentrated on the metrological aspects of experimental
dosimetry and the evaluation of the accuracy of the calculated doses. The
wide use of NACP-type plane parallel (PP) chambers in electron beam
dosimetry and the reported individual variations of the type-related critical
parameters of these chambers in a 60Co gamma beam used for calibration
have lead to investigations of different calibration methods of  NACP PP
chambers [Publ. IV]. In photon beam dosimetry the validity of the commonly
used beam specifier, i.e. the tissue-phantom-ratio, 2010TPR , as a general
beam specifier is investigated and the accuracy of the alternative photon
beam specifier, i.e. the percentage depth dose at 10 cm depth, %dd(10), is
studied through the Monte Carlo (MC) simulations of photon beams [Publ.
III]. For epithermal neutron beams the twin ionization chamber technique
has been applied, so far, to determine only the epithermal+fast neutron
dose and the gamma dose. In this study the feasibility of ionization
chambers for the measurement of the total neutron dose and the gamma
dose is investigated [Publ. V]. To investigate the accuracy of calculated
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doses by treatment planning systems (TPS) of electron and photon beams
and to improve test methods for QA an intercomparison of TPSs was
performed [Publ. I and II]. For epithermal neutron beams a comparison of
calculated and measured dose distributions is also presented [Publ. V].
The dosimetry procedures of epithermal neutron beams for BNCT are
described parallel to those of electron and photon beams. The methods and
formalism for the measurement of dose in the reference conditions, the
methods for dose calculation by TPSs, and the principles for QA in
radiotherapy are described. Finally, the outcome of the study is discussed
and the implementations of the results into the international CoPs for
dosimetry are described.
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3 QUALITY OF RADIOTHERAPY
DOSIMETRY
3.1 Dosimetric accuracy requirements
In radiation therapy with external radiation beams the absorbed dose at the
specification point in a patient should be known with an overall uncertainty
of 3.5% (1sd)* [16, 44, 74, 117]. The main reason for the requirement of high
accuracy in dose delivery is the typically narrow dose margin between the
dose needed for tumor control and the dose causing complications for
healthy tissues. The size of the dose margin depends on the biologic
characteristics of tissues, the size and shape of the irradiated tissue
volumes, the quality of radiation, as well as the dose fractionation regime.
Due to individual nature of the dose margin, 3.5% (1sd) uncertainty can be
regarded as a general level accuracy requirement for dose delivery [16, 74,
117]. Besides the individual treatments, the high accuracy in dose delivery
is essential to enable a reliable analysis and a comparison of results of
different radiation therapy techniques and modalities [22, 23, 44].
In BNCT the succcess of a treatment depends on a number of parameters
including tumor location and depth, boron content in tumor and healthy
tissues, and neutron fluence. The biologic effectiveness depends not only on
the quality of ionizing particles present in the tissues, but most importantly
on the intracellular boron concentration [9]. Furthermore, the intracellular
boron concentration is critically dependent on the type of the boron
pharmaceutical used. Mainly due to this complicated, microdosimetric and
pharmacokinetic nature of producing the therapeutic effect in BNCT,
generally accepted accuracy requirements for the delivered dose are
difficult to define and so far they do not exist.
In typical BNCT treatments of brain tumors 30% to 50% of the dose in the
brain is produced by the beam radiation components (non-boron dose) [9,
93]. On the other hand, the dose from the neutron capture by boron is
directly proportional to the thermal neutron fluence, also responsible for
production of the main fraction of the beam dose in tissues. The delivery of
                                                
* According to the recommendations of  International Committee for Weights and Measures
(CIPM) the estimated accuracy is expressed in uncertainties. The uncertainties are classified to
those estimated by statistical means (Type-A) and to those estimated by other means (Type-B).
Both types of uncertainties are expressed by standard deviation (1sd). The overall uncertainty of a
process includes combination of both types of uncertainties from all steps in a process [53].
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a relatively high beam dose to tissues requires therapeutic accuracy
intrinsically and the requirement of accuracy is even more pronounced due
to the linkage of boron and non-boron doses through the thermal neutron
fluence. Based on the arguments above the same level of accuracy as in the
electron and photon radiotherapy can be justified for the beam dose in
BNCT.
In the quality standards of ISO the quality is defined as “the totality of
features and characteristics of a product or service that bear on its ability to
satisfy stated or implied needs” [55]. Based on the requirements for curative
radiotherapy it can be stated that the “need” for radiotherapy dosimetry is
the “need of accuracy”. Furthermore, to achieve or even get close to the
required accuracy the features of the whole treatment and dosimetry
procedures have to be considered.
3.2 Treatment and dosimetry procedures
The treatment procedures for external electron and photon radiation
therapy and for BNCT radiotherapy includes several sequential phases. The
schematic presentation of the treatment procedures is presented in Table I.
Treatment planning includes all the steps prior to treatment delivery. Dose
planning is a process used to prescribe the target volume, dose and the dose
fractionation regime and also the number, orientation, type and
characteristics of the radiation beams [16, 30]. In BNCT the planning for the
concentration and distribution of boron in a patient is a part of dose
planning [9, 27].
In the external electron and photon beam dosimetry the dosimetry chain
starts by the realization of the dose quantity in the PSDL leading by an
unbroken chain of calibrations of ionization chambers to the measurement of
the absorbed dose to water in the reference conditions in a clinic and,
finally, ending to the calculation of the dose to a patient [30, 39, 44, 46]. The
beam specific reference dose of the treatment unit is used for the
calibration of the beam monitoring detectors (or the timer) and for the
normalization of the further relative dose measurements required [39, 44].
Dosimetry enters the treatment procedure at the phase of dose planning,
where the measured characteristics of the beam and the calibration factors
for beam monitor detectors are used as an input [2, 46, 110].
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Table I. The schematic presentation of the treatment procedure of external
electron and photon radiation therapy and BNCT [9, 16, 27, 30, 46, 48, 65,
93].
Treatment procedure
Treatment planning Treatment
delivery
Follow-up
Tumor
localization
Dose planning Plan verification
· CT, MRI,
X-ray
imaging
· Patient
positioning
(fixation)
· Prescription of
target volume, dose
and fractionation
· Dose calculations
by TPS
(optimization)
· Plan of the boron
concentration and
distribution in the
patient. 2)
· Simulation of the
patient set-up
· Simulation of the
radiation fields
in the patient by
X-rays 1)
· Patient set-up
· Dose delivery
· Verification
- recording and
verifying systems
- in-vivo dosimetry
- portal imaging 1)
· Determination of
boron
concentration
   (blood samples)2)
· Medical
examinations
of the patient
· Evaluation of
results
1) Actions performed only in electron and photon beam radiotherapy.
2) Actions performed only in BNCT.
The dosimetry procedure of epithermal neutron beams in BNCT consists of
the same elements as the dosimetry chain of electron and photon beams.
The differences arise from the complexity of radiation components and from
the variety of dosemeters. The physical quantity of the neutron beam
related to the therapeutic dose is the thermal neutron fluence. The thermal
neutron fluence rate is typically determined by a metal foil activation
technique. The measured neutron fluence is traceable to the standards of
activity [43, 45]. With a twin ionization chamber technique it is possible to
determine both the neutron and gamma doses traceable to the standards of
dose quantities (air kerma and absorbed dose).
Metrology in radiotherapy dosimetry deals with the dose measured in the
reference conditions in a clinic and is mainly related to its traceability to the
international measuring system. Besides the actual determination of the
dose to a patient (the dosimetry chain) a lot of dosimetry actions are
required in measurements of the input data for TPS, in QA of treatment
units and TPSs, and in-vivo dose measurements.
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3.3 Quality assurance of dosimetry
It can be summarized that the elements affecting the quality of dosimetry in
radiation therapy are the means of dosimetry (methods and equipment) as
well as the possibilities and practice to carry out the dosimetric actions
(quality policy, organization, education). The means of QA for dosimetry are
the establishment of performance criteria, quality control (QC) and quality
audit measures [1, 2, 30].
Through the use of the methods, data and dosemeters of CoPs it is intended
to unify both the accuracy of dose with respect to the absolute dose and the
consistency of dosimetry between different radiotherapy clinics and
modalilities. The dosimetry recommendations include also guidance for QC.
The performance requirements for manufacturing of the medical electrical
radiation therapy equipment and the recommendations for QC of this
equipment are established by the International Electrotechnical Commission
(IEC) [50, 51]. The basic structure of the organization of a radiotherapy
clinic and the expertise of the staff of the clinic are outlined in the published
comprehensive QA recommendations [1, 30].
Quality audit site visits and mailed dosimetry services are organized by
SSDLs and by other national and international organizations [28, 34, 58,
114]. Dosimetric intercomparisons are a widely used method for external
verification of the quality of dosimetry. The intercomparisons are performed
either at some specific level in the dosimetry chain [10, 71, 102] or in order
to evaluate some specific treatment technique [21].
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4 MEASUREMENT OF DOSE IN THE
REFERENCE CONDITIONS
By an ionization chamber the absorbed dose to a medium, D can be
determined according to a relation:
QNCD = (4.1)
whereQ  is the measured charge, N is the individual calibration factor of the
chamber for the dose quantity and beam quality used in the calibration
laboratory, and C is the conversion factor of the calibration from the
laboratory irradiation conditions to the reference conditions in a clinic.
ForQ  the corrections for the influence quantities of charge collection and
for the ambient climatic conditions are required [51]. In a clinic the
reference absorbed dose in external electron and photon beams is measured
in defined reference conditions in a water phantom [39]. The reference
conditions fix the beam geometry (attenuation and scattering conditions)
and the position of the chamber in the beam so that the conversion factor
can be specified.
In a mixed neutron and gamma beam the neutron dose can be determined
by a tissue equivalent (TE) ionization chamber [47]:
NQ
C
D
C
D
TE
K
TE
Kn
n =+
,, g
g
(4.2)
In Equation 4.2  nD and gD are the neutron and gamma doses. 
TE
KnC , and 
TE
KC ,g
are the conversion factors relative to air kerma for neutron and gamma
radiation qualitites, respectively. To determine both the gamma and
neutron doses a twin ionization chamber technique can be applied and a
similar equation as for a TE chamber (Equation 4.2.) can also be written also
for a non-hydrogenous neutron insensitive gamma ionization chamber [47].
.
4.1 Calibration of ionization chambers
In the calibration process the calibration factor N  and the conversion
factors C are determined (Equations 4.1 and 4.2). The accuracy of
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N depends on
the characteristics of the chamber and the calibration method used. N  is
determined by a direct comparison of the ionization chamber to a standard
dosemeter. The dose quantity, in terms of which N  is determined, is either
the air kerma or the absorbed dose to water in a 60Co gamma beam or in a
beam with a quality closer to the user beam. In the SSDLs, typically, only
60Co gamma sources are available for high energy calibrations. If other beam
qualities are used, the calibrations have to be performed either in a PSDL or
in a radiotherapy clinic.
The conversion factors C  can be determined experimentally by using a
reference dosemeter and specific beam qualities or theoretically by methods
based on the cavity theories of dosimetry [8]. The accuracy of C depends on
the dose quantity used to determine N  (air kerma or absorbed dose), the
reference dose quantity used in a clinic, the characteristics of the radiation
beams and the characteristics of the chamber. In the dosimetry of electron
and photon radiotherapy the reference dose quantity is the absorbed dose to
water and the measurements are performed in a water phantom [39, 44].
For neutrons the fluence to dose conversion depends critically on the
chemical composition of the material, and the reference dose is defined
directly to the target tissue material e.g. “ICRU adult brain” for treatments
of brain tumors in BNCT [47, 56, 93, 100]. In spite of the definition of the
reference dose to the target tissue material for neutrons, the dose
measurements and calculations can be performed in “simple” materials as
water or PMMA [91, 104]. For reference dosimetry of photon beams small (<
1 cm3), air filled, graphite wall thimble type ionization chambers are
recommended. For dose measurements in electron beams, depending on the
electron beam energy, both thimble chambers and flat, coin shaped PP
chambers with graphite windows are suitable [51, 39]. For neutron
dosimetry ionization chambers made of TE plastic and flushed with TE gas
are recommended [47].
The formalism of the conversion factors C , based on cavity theories for
dosimetry,  for the ionization chambers typically used in the electron,
photon and neutron dosimetry are summarized in Table II.
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Table II. Conversion factors C  for typical ionization chambers in electron,
photon, and neutron dosimetry. Abbreviations are explained in the text. [7,
39, 40, 47, 81]
Type of
the
ionization
chamber
Dose quantity
and radiation
quality used
for individual
calibration of
the chamber
Radiation
quality
to be
measured
Conversion factor
Thimble Air kerma
60Co gamma
Electrons
and
photons up
cairW
uairW
c
air
wall
wall
airS
u
water
airS
attkgKC )(
)(
])/()/[(
])/[(
)1(
rmr
r
-=
Plane
parallel
Air kerma
60Co gamma
Electrons
up
cairW
uairW
u
water
airSattkmkg
pp
KC )(
)(
])/[()1( r-=
Thimble
and plane
parallel
Absorbed dose to
water
60Co gamma or
electron/photon
Electrons
and
photons
cp
up
cairW
uairW
c
water
airS
u
water
airS
DC )(
)(
])/[(
])/[(
r
r
=
TE-thimble Air kerma
60Co gamma
Neutrons
up
cgasW
ugasW
c
air
wall
wall
gasS
u
tissue
wallK
wall
gasr
attkg
TE
KnC )(
)(
])/()/[(
][
)1(,
rmr
-=
In Table II. 12)/( rS , 
1
2)/( rm and 
1
2)(K  are the ratios of mass collision
stopping powers for electrons, ratios of mass absorption coefficients for
photons, and ratios of kermas for neutrons, respectively. All ratios are
expressed in medium 1 to medium 2. wallgasr  is the gas-to-wall conversion
factor for neutrons. W is the energy  required  to  produce  an ion  pair in
the gas of  the ionization chamber.
mk  is the factor which takes account of the non-air equivalence of the
chamber wall in a 60Co gamma beam. attk  is the correction factor for
attenuation and scatter of photons in the chamber relative to air in a 60Co
gamma beam.  p is the product of several factors and takes account of the
perturbation of the electron and photon (or neutron for TE chamber)
fluences in the chamber compared to those in the phantom medium. g is the
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fraction of energy of secondary charged particles that is lost to
bremsstrahlung in air in a 60Co gamma beam (value of g is 0.003) [39, 47].
Subscripts c and u refer to the calibration and user beam qualities,
respectively.
In this work the calibration procedures of NACP PP chambers [72] are
studied
and the individual variations of the values of factors mk , attmkk and cp are
determined experimentally for several PP chambers [Publ. IV].
The variation of KC , 
pp
KC , and DC  relative to the user beam quality is
mainly defined by the variation of waterairS )/( r  and a minor contribution is
induced by up . For electron and photon beams the value of the ratio
cairuair WW )/()( can be considered to be unity [7, 40]. In the reference
conditions in water for typical accelerator spectra the variation of the values
of waterairS )/( r  is approximately 13% for electron beams and 6% for photon
beams [7, 40]. In electron beams the change of electron spectra and
water
airS )/( r relative to the depth in water have to be considered. For neutrons
the values of TEKnC , change approximately with a factor of three relative to
neutron energy due to change of critical parameters brainTEK and TEW  [56,
100, Publ.V]. In this study the values of TEKnC ,  were evaluated for the total
epithermal neutron spectra (including thermal neutrons) and a change of
13% relative to the depth up to 150 mm was found [Publ.V]. According to the
results of Raaijmakers et al. the variation of the value of TEKnC ,  is
approximately 5 to 6% for the epithermal and fast components of the
spectra they used [92]. For a total neutron spectrum the value of TEKnC ,  is
close to 1.30, whereas for epithermal and fast neutrons it is close to 0.90.  In
all the studies mentioned for neutrons the changes of the values of TEKnC ,  are
referred to brain tissue and assuming the value of up to be equal to one.
4.2 Specification of beam quality
For the evaluation of the conversion factor C , the energy spectrum of the
particle fluence of the beam has to be specified. In the dosimetry of electron
and photon beams the spectrum of an individual beam is not explicitly
determined. In these beams relatively simple, easily measurable beam
quality specifiers are used [7, 12, 15, 39, 40]. These beam quality specifiers
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are based on the indication of dose or ionization characteristics relative to
the depth in water at a specific beam geometry. The relations between a
beam specifier and waterairS )/( r  and p are determined experimentally as well
as by MC calculations. In CoPs these relations are given as tables or figures
for typical accelerator spectra and common ionization chambers [7, 39].
In the CoPs for electron beams the selections of waterairS )/( r  and p are based
on the use of two measured beam energy specifiers, i.e. the depth of 50% of
the maximum dose, R50, and the practical range of electrons, Rp [39, 40, 52,
80]. First, R50 is used to determine the mean energy at the surface of the
phantom, 0E [12]. 0E , in turn, and Rp are used to determine the mean
energy at the reference depth in a phantom, ZE . The realtions of 0E , Rp,
and ZE  are based on MC simulations of the beams. Finally, 0E is used for
the selection of waterairS )/( r  and ZE  for the selection of  p.
The accuracy of R50 as an electron beam specifier depends on the
characteristics of electron scattering and on the level of photon
contamination in the beam in water [12, 39]. In the recent studies Sorcini et
al. investigated the effects of the energy and angular spread on the
characteristics of the depth dose curve in water produced by a high energy
electron beam [108, 109]. They also introduced novel range parameters for
evaluation of 0E [109]. The effect of photon contamination in electron beams
has recently been studied by Klevenhagen et al. [62], Ding et al. [25], and
Sorcini et al. [108, 109]. According to these studies the absorbed dose
determined by ionization chambers in heavily photon contaminated electron
beams ( 0E ³ 17 MeV)  may be too low, even as much as 1.0 to 1.2%. Ding et
al. and Sorcini et al. have also developed methodologies to take account of
the contribution of contaminant photons to the measured absorbed dose in
electron beams. A simplified procedure where both the reference depth and
water
airS )/( r are defined by 0E  is presented by Burns et al. [19]. In the
approach by Rogers et.al., where  the  absorbed d ose to
water is used as a calibration quantity, the conversion factor DC  is
expressed directly by R50 [98, 99].
For photon beams a widely adopted beam quality specifier is the tissue-
phantom-ratio, 2010TPR  [7, 15, 39]. 
20
10TPR  is defined as a ratio of the
absorbed dose to water at the depth of 20 cm to that at the depth of 10 cm
on the central beam axis in a water phantom, with a 100 cm source-to-
detector-distance and a field size of 10 cm × 10 cm at the detector level. The
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precursor of 2010TPR  , the ionization ratio, J10/J20, was used to specify the
nominal accelerating potential, waterairS )/( r , and p [14, 80]. Other types of
photon beam quality specifiers, mainly used to specify the nominal
accelerating potential, are the depth at which the dose fell to 80% of the
maximum dose, d(80%), and the percentage dose at the 10 cm depth,
%dd(10) [17, 67]. In this study the validity of the %dd(10) as a beam
specifier i.e. to determine waterairS )/( r  is investigated [Publ. III]. Karlsson
and Nyström have demonstrated the use of a device for measuring the half
value thickness of a photon beam in a narrow water column. The half value
thickness they used to determine waterairS )/( r especially in non-reference
conditions [60, 89].
For accurate neutron dosimetry the characterization of the neutron
spectrum is essential [47]. For epithermal neutron beams this requirement
is emphasized due to the spread of the neutron spectrum at the thermal
energy range and due to the energy dependence of dosemeters. For the
determination of the neutron spectrum in a phantom a set of metal
activation foils and wires with different cross-sections relative to neutron
energy has been applied [43, 45, 91]. In this work the neutron spectrum was
calculated by using deterministic methods and verified by the activation foil
technique [Publ. V].
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5 CALCULATION OF DOSE TO A PATIENT
5.1 Treatment planning systems
The core of a TPS is the algorithm responsible for the calculation of the dose
distribution in a patient. The algorithm should take into account all beam
geometries and beam modification devices as well as the full extent of the
patient anatomy [46]. The dose calculation algorithms can be classified into
“correction” based approaches (matrix methods, methods of beam
generating functions, and methods of separation of the primary and
scattered dose components) and into those using beam modelling [22, 46, 70,
83]. The “correction” algorithms reconstruct the beam in a homogenous
medium and use separate corrections for beam shaping, patient contour,
and heterogeneities. With the “correction” algorithms a separate calculation
procedure is also required for the calculation of the output factors (monitor
units) of the modified beams [70]. The “correction” based algorithms are
typically 2D calculation approaches, although permitting the dose in 3D
locations. By the model based algorithms the fluence transport in a medium
is directly modelled by either deterministic (radiation transport equations
and 3D convolution methods) or stochastic means (MC calculations). The
model algorithms are suitable for efficient 3D calculations and capable of
calculating the dose in “absolute units” i.e. dose per unit fluence.
In spite of the differences in the principles for dose calculation, the
“correction” and model based approaches also have a lot of common
features. All calculation algorithms require some measured data of the beam
as an input. In the model based approaches the measured input data is
mainly needed for “tuning” the beam specific parameters [70]. All dose
calculation methods are also approximative: the “correction” based
approaches due to their initial nature and the model algorithms due to the
limited calculation time in clinical use and/or the inadequate input data.
Although the trend in TPSs for electron and photon beams is towards the
3D convolution model based dose calculation algorithms [37, 70], the
“correction” type dose calculation approaches are still common [2, 4, 101].
Due to long calculation times, MC techniques are still mainly used as a
complementary method for convolution techniques [62, 102, 122] and as a
reference method in the verification of other calculation methods [24]. An
extensive list of MC based treatment planning projects is included in the
work of DeMarco et al. [24]. In this study the accuracies of the six TPSs,
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using “correction” type dose calculation approaches for electron and photon
beams, were compared [Publ. II].
For the treatment planning in BNCT the fluence and dose calculations are
mainly performed by MC methods [83, 125]. Deterministic radiation
transport calculation methods, common in reactor physics, are also used for
dose calculations in epithermal neutron beams [83]. Raaijmakers et al. have
modified algorithms designed for external electron and photon radiotherapy
and used them for dose calculations of the mixed epithermal neutron and
gamma beam in BNCT [94].
The implementation of a modern conformal treatment technique requires a
TPS with totally 3D dose calculation algorithms. An efficient use of a 3D
algorithm also requires accurate 3D patient data and a visualization for 3D
images [82, 110]. These characteristics are standard features in the newest
TPSs as well as software tools for image fusion, automatic contouring,
beam’s eye view display, digitally reconstructed radiographs, and dose
volume histograms [2, 101]. All these features have to be included also in
the QA procedure of a TPS [2].
According to ICRU the calculated relative doses should not differ by more
than 2% (low dose gradient area) or 2 mm (high dose gradient area) from
dose measurements [46]. A detailed summary on the performance
requirements for external electron and photon beams has been published by
Van Dyk et al. [120]. The tolerance values by Van Dyk et al. can be
summarized as 3–4% (/ 4 mm) for photons and 5–7% (/ 5 mm) for electrons.
The percentage tolerance values are expressed relative to the maximum
dose higher values being typically adopted at high dose regions. Tolerances
in the distance (mm) are for high dose gradient regions. Tolerance values
are valid for tests of a complicated geometry using radiation fields of a
modified shape and intensity together with inhomogeneities. Van Dyk et al.
considered their tolerance values as practical achievable criteria and they
also pointed out that the criteria are not limits beyond which no further
improvements are necessary. For the accuracy of the calculation of the
beam output (absolute dose) they recommended a tolerance of 1%.
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5.2 Verification of calculated doses
In commissioning and in QA of a TPS, to verify the accuracy of the
calculated doses, calculated and measured doses are compared. Typically
the comparisons are performed in separate tests for different shapes of
beam and phantom surface and inhomogeneities [105, 120]. The calculated
doses are also verified by the in-vivo measurements of a patient and the
measurements of the delivered dose in a phantom [2, 106, 120]
The accuracy of the calculated dose depends on the accuracies of measured
data, data entry and output, calculation algorithm, and the physical data
[46, 88, 120]. For the measurement of the comparative relative doses (non-
reference geometries) a variety of dosemeters can be used. The selection of
the most suitable dosemeter should be based on the optimization of the
energy, angular, and dose rate dependences of the dosemeter. For electron
and photon beams typical on-line dosemeters are small ionization chambers
and diodes. Passive dosemeters, such as TLD and films, can be used,
especially in solid phantoms [61, 71]. For dosimetry in phantoms, the novel
application of fricke dosimetry is the use of fricke gels read out by nuclear
magnetic resonance [90]. In this study lithium tetraborate (Li2B4O7) TLD,
ionization chambers, silicon diodes and diamond detectors are used for the
measurements of relative dose distributions in electron and photon beams
[Publ. I , Publ. II].
For the verification of calculated doses accessory softwares have been
developed, although not widely implemented in the commercial TPSs [2, 24,
35, 69]. AAPM Task Group 23 provides a test package for the quantitative
analysis of treatment planning systems for photon beam radiation therapy.
The test package includes measured input data and comparative data for
the verification [4]. The Collaborative Working Group of the National
Cancer Institute in the USA also provides measured verification data for
electron algorithms [105].
For in-vivo dosimetry in electron and photon beams semiconductor diodes
and TLD are used and recommended [75, 119]. Methods to use electronic
portal image devices for in-vivo dosimetry of the patient and for QA of
accelerators have been developed. [11, 78, 119].
For the experimental verification of calculated doses of epithermal neutron
beams the dosemeters used in fast neutron therapy can be used if special
attention is paid to their response for thermal neutrons [45, 73]. In BNCT
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dosimetry for the detection of thermal neutron fluence in phantoms,
activation foils [91, 112], boron doped proportional counters [5, 112], and
diodes [29, 36] have been used. For neutron and gamma dosimetry, TLD
[115, 124], fricke gels [33] and microdosimetric techniques [66, 123] have
successfully been applied. Especially for in-vivo dosimetry in BNCT prompt
gamma detection from the neutron capture of boron has been developed
[121].
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6 DISCUSSION
In the estimation of the overall uncertainty of a process the uncorrelated
sub-uncertainties are added in quadrature and the importance of the largest
uncertainties is pronounced [54]. In the dosimetry chain for electron and
photon beams the “weakest links” are the determination of the calibration
factor of an ionization chamber for the user beam quality and the calculation
of the dose to a patient [16]. For dosimetry of epithermal neutron beams in
BNCT the same steps as for electron and photon beam dosimetry can be
considered as most meaningful. This work is concentrated on studing these
steps of the dosimetry procedures.
6.1 Calibration of ionization chambers
At the time of closing this study the general attempt to calibrate
radiotherapy dosemeters in terms of absorbed dose to water instead of air
kerma is going to be fullfilled. For electron and photon beams, AAPM, IAEA
and ICRU are preparing dosimetry recommendations based on absorbed
dose [42, 49, 99]. Due to the elimination of conversions of quantities the
advantages of the absorbed dose to water calibrations are obvious for photon
dosimetry [7, 96, 97], whereas for electrons these advantages are partly lost
[98]. Primary standard equipment for absorbed dose are mainly developed
for photon radiation [12] and the radiation quality dependent systematic
components of the uncertainties in the dose conversion procedure for
electrons are not cancelled out to the same extent as in case of photons [98].
However, regardless of the quantity used for calibration (air kerma or
absorbed dose to water), waterairS )/( r and p of the user beam are directly
related to the measured absorbed dose i.e the dose to a patient.
For electron dosimetry by PP chambers, the chamber to chamber variations
of the fluence perturbation effects ( mk , attmkk  and cp ) in a 60Co gamma beam
increase the uncertainty of the measured dose. In CoPs these effects are
assumed to depend only on the type of the chamber and the beam quality. If
a PP chamber is calibrated in a 60Co gamma beam (for air kerma or absorbed
dose to water) the uncertainty of the absorbed dose measured in the
reference conditions in an electron beam by this chamber is 3.4 to 3.5% (1sd)
[40]. If a PP chamber is calibrated for absorbed dose to water in a high
energy electron beam, the uncertainty of the measured dose is 2.9% (1sd),
even if a thimble type chamber with an air kerma calibration is used as a
secondary standard [40]. The described improvement of the accuracy is
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mainly due to the elimination of the individual variations of the fluence
perturbations of  PP chambers in a 60Co gamma beam. In this study 3%
chamber to chamber variations of mk , attmkk  and cp  factors are found*. Publ.
IV is adopted as a reference study in the CoPs for electron dosimetry by
IAEA and IPEMB [40, 52].
Since Publ. IV, Nilsson et al. have studied the effects of chamber and
phantom materials on the perturbation factors pu of PP chambers in
electron beams [84].
The results of Nilsson et al. verify that for NACP chambers up  in electron
beams is close to  unity in water, the  deviation  being less than 0.5%.
However,
as related to up , even with well guarded chambers the contribution of lateral
scatter might not be negligible [84]. Ding and Cygler have determined up
relative to R50 in electron beams for other types of PP chambers using
NACP PP chambers as a reference [26].
Burns et al. have demonstrated deflections from theoretical predictions in
the ion collection efficiency (recombination effect) of NACP PP chambers in
electron beams of high dose per pulse [20]. Using the commonly applied two
voltage method for the determination of the recombination correction,
Burns et al. obtained up to 1% over estimation for recombination correction.
For the accurate calibration of NACP PP chambers in electron beams, the
total saturation behaviour of the collection efficiency has to be determined.
In the dose measurement the effect of the overestimated recombination is
cancelled out if the same “dose rate per pulse” and collecting potentials are
used both in the calibration and in the actual dose measurement [20, 40].
The possible overestimated recombination effects can partly explain the
large variations of the perturbation effects of PP chambers obtained in this
study. This item is under research at the moment. Nisbet et al. have studied
the polarity effects of the collection potential in NACP chambers and
emphasize the requirement of polarity correction i.e. the use of both
polarities of the collection potential in accurate measurements [85]. The
methods of accurate recombination and polarity corrections have been
implemented in the recent dosimetry CoPs of IAEA and IPEMB [40, 52].
                                                
*
 The manufacturing of the NACP PP chambers by Dosetek company has been finished in 1997
(Varian-Dosetek Oy, Metsäneidonkuja 8 FIN-02130 Espoo, Finland). At the moment, NACP type
chambers are manufactured only by Scanditronix Medical AB, Stålgatan 14, S-754 50 Uppsala,
Sweden.
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For the calibration of PP chambers in electron beams, the arrangement of
laboratory conditions in a clinic can be difficult due to practical
considerations. In Finland, the calibrations of PP chambers are performed
by the staff of the SSDL-Helsinki, during their regular site visits to clinics.
By this arrangement the same reference thimble chamber can be used as a
standard and the consistency of calibrations can be increased.
In dosimetry of epithermal neutron beams, the main drawback of using a TE
ionization chamber for neutron dose determinations in a phantom is the
subtraction of the signal due to large gamma dose [Publ. V]. In this study, in
a highly thermalised neutron beam the uncertainty of 6% (1sd) of the
gamma dose is manifested as an uncertainty of 18% (1sd) in the neutron
dose measured by a TE chamber. Another significant source of uncertainty
is the uncertainty of the conversion factor TEKnC , . For an A150-plastic TE
ionization chamber TEKnC ,  to brain tissue can be determined with an
uncertainty of 7 to 10% for the total epithermal neutron spectrum [Publ. V].
The energy response of a chamber and the uncertainty of TEKnC ,  can be
reduced if TE chambers made of brain tissue equivalent materials instead of
muscle tissue equivalent A150-plastic can be used. So far, only liquid brain
substitute materials are  available [104]. The uncertainty of TEKnC ,  can also be
expected to be reduced through the calibrations of chambers in neutron
beams. Unfortunately, the availability of these types of calibrations in
neutron beams at PSDLs is limited. The total uncertainty of the
determination of the neutron dose to brain tissue by an A150-plastic TE
chamber in a phantom is 15 to 20% [Publ.V, 93, 100].
6.2  Specification of photon beam quality
For typical clinical photon beams waterairS )/( r can be expressed within a
variation of 0.7% relative to 2010TPR  and with an uncertainty of 0.7% (1sd) [6,
7, 39, 86]. For 2010TPR  as a general photon beam specifier the following
limitations can be stated [Publ. III, 68]: a) The relation between
water
airS )/( r and 
20
10TPR  depends on the filtration of the beam; for the light
filtered beams as used in some PSDLs as well as for the high energy
racetrack microtron beams differences up to 1.0% in waterairS )/( r compared to
the typical clinical beams are found for the same value of 2010TPR . b) The
relation between waterairS )/( r  and 
20
10TPR  is not linear and the accuracy of
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20
10TPR  is decreased at higher energies; 1% change in 
20
10TPR  leads to 0.4%
change in waterairS )/( r  at the 
20
10TPR   value of 0.8  and to 0.1% change at the
20
10TPR  value of  0.7. c) As a ratio, 
20
10TPR  is not a very illustrative parameter
for beam specification.
In this study the characteristics of 2010TPR  and an alternative photon beam
specifier, %dd(10), are investigated by simulating photon beams by an EGS4
MC code [Publ. III]. A linear relationship within 0.2% between waterairS )/( r and
%dd(10) was found both for clinical and for lightly filtered photon beams.
The main disadvantage of %dd(10) as a photon beam specifier is the effect of
the electron contamination of the beam at the depth of the dose maximum.
The contribution of electrons to the dose at the depth dose maximum in the
phantom is between 2 to 5% and increases with the increasing beam energy
[Publ. III, 68, 107]. Without corrections in clinical photon beams the effect of
contaminant electrons introduces a maximum deviation of 0.7% to
water
airS )/( r  when determined by %dd(10). As a continuation to Publ. III of
this study Li and Rogers have studied methods to eliminate the
contaminant electrons by metal filters [68]. They define a cubic relation
within 0.2% between waterairS )/( r  for a realistic, contaminated photon beam
and %dd(10) when the contaminant electrons are excluded from the beam by
a 1 mm thick lead filter.
In the measurement of %dd(10), attention has to be paid to the type of the
ionization chamber used. Due to the change of perturbation factors, pu, of
thimble and cylindrical chambers relative to the depths of the dose
maximum and 10 cm in water [Publ. III], PP chambers are preferred in the
measurements of %dd(10).  Mainly for practical considerations, especially
for the use of a lead filter, the outcome of the use of %dd(10) as a photon
beam specifier for dosimetry will be verified through the experiences in
practical dosimetry work. Comparative dose measurements using different
beam quality specifiers will give more information of practical aspects. This
kind of a study is planned for the future. Publ. III of this study and the
study of Li and Rogers [68] are used as a basis for adopting %dd(10) as a
photon beam specifier in the forthcoming dosimetry recommendations of
AAPM [99].
The exclusion of the contaminant electrons from a photon beam is desirable
not only for dosimetry but also for reducing the skin dose of a patient. It can
be expected that the use of the %dd(10) specifier in dosimetry will
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encourage the manufacturers to develop medical accelerators with less
contaminated photon beams.
6.3 Verification of calculated doses
For electron dose calculations only a few intercomparisons of TPSs have
been published since Publ. II. Dose calculation algorithms for electrons have
been tested by several groups, most recently by Samuelsson et al. for a 3D
pencil beam algorithm [102]. They used basically the tests described by the
Collaborative Working Group of the National Cancer Institute [105].  The
general consistency between measured and calculated relative dose
distributions found by Samuelsson et al. was within the 5 to 7% (/ 5 mm)
limits stated by Van Dyk et al. [120]. The largest deviations detected by
Samuelsson et al. were near the edges of the radiation fields (7%) and in
and under the bone and lung inhomogeneities (2 to 4mm). The authors
considered the 4 mm deviations related to the doses of the lung
inhomogeneity too large to be fully accepted [102]. The calculated results for
the beam output were within 1% of the measured values. Although the tests
used by Samuelsson et al. are not totally comparable to the tests used in
this study [Publ. II], the results of both studies illustrate the same
behaviour of the limitations of the dose calculation algorithms. In both
studies the largest inaccuracies in dose calculations were detected in the
lung inhomogeneities where calculations overestimate the dose. In this
study the maximum differences of measured and calculated doses were 10%.
Since Publ. II, intercomparisons for photon dose calculations by TPSs have
been performed at least by Van Bree et al., Masterson et al., Aird et al.,
Cheng et al. and by Alam et al. [3, 4, 21, 71, 92, 118]. Van Bree et al. and
Cheng et al. tested the accuracy of the calculated tangential beams in breast
treatment [21, 92, 118]. Van Bree et al. circulated a breast phantom in six
clinics having different TPSs of 2D calculation algorithms. In the study of
Cheng et al. TPSs also with 3D calculation features were included in the
intercomparison and no measurements were performed. Aird et al.
investigated the consistency of the measured and calculated doses of nine
TPSs using a “head and neck” phantom and a “bronchus” phantom.
Mastersson et al. tested six non-commercial 3D algorithms and Alam et al.
compared the calculations of two TPSs. In all these tests the general
consistency of the measured and calculated relative doses were 3 to 4%
(/3mm). Similarly, as for electrons, the largest discrepancies were related to
the dose calculations near or in the lung inhomogeneities. In a few studies
also large individual (clinic related) discrepancies were found. Van Bree et
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al. detected up to 10% and Aird et al. up to 7% differences between the
calculated and measured doses. These were mainly explained by the
inaccuracies in the input data [3, 92, 118]. Alam et al.  detected up to 19%
inaccuracies of the calculated doses for a pencil beam based algorithm. They
thought the discrepancy to be related to the inaccuracies in the user
dependent fitting parameters of the algorithm [4]. The calculated beam
output was typically within the limits of the estimated uncertainty of the
measured dose, i.e.1% (1sd), expressed relative to the dose in the reference
conditions in a clinic.
The accuracy of the calculated photon doses was also verified in the large
intercomparison of 62 radiotherapy clinics by Thwaites et al. and the similar
intercomparison of 4 clinics by Nisbet et al. [87, 113]. In these studies the
consistencies of the measured and calculated doses were compared in five
points in a simple phantom with a lung substitute insert. As in the TPS tests
the general consistency of the calculated and measured doses (including the
beam output in these comparisons) was better than 3 to 4%. Thwaites et al.
found also large individual variations of –8% to +16% for a few TPSs. The
largest deviations were due the exclusion of the lung inhomogeneity
correction and the software error of a TPS.
For photon beams, in addition to the intercomparisons mentioned, a large
number of tests are performed for individual algorithms and treatment
techniques. Intensive studies for a model based 3D pencil beam calculation
algorithm have been performed by Knöös et al. and Hurkmans et al. [38, 63,
64]. The limitations of the algorithm were clearly illustrated as 3 to 14%
deviations of relative doses with an increasing trend relative to the
increasing beam energy being detected in and close to lung inhomogeneities
[64]. In the lung inhomogeneity study MC calculated dose distributions were
used as a reference. In phantom studies for small fields and curved surfaces
(simulated head and neck area) the algorithm overestimates the dose from 2
to 5% [38]. The absolute output was calculated with an accuracy better than
3% [63].
In the studies reviewed above, ionization chambers, diodes, TLD, and film
dosimetry were used for the measurement of doses. For the same type of
Li2B4O7 pellets as used in this study [Publ. I] the energy dependence has
been studied by MC simulations by Mobit et al.. [76]. According to their
results the energy response (relative to dose in water) of Li2B4O7 pellets is
constant within 1% in the energy range of 2 to 20 MeV of monoenergetic
electrons. For photons this variation was 3% in the energy range of 1 to 10
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MeV [76]. The findings of Mobit et al. support the results of this study
[Publ. I], that considering the energy response, the Li2B4O7 pellets are well
suitable for the measurements of relative dose distributions in a tissue
equivalent phantom in electron and photon beams. The tests used for
intercomparison of TPSs in this study [Publ. II] are similar to those used
more recently [3, 4, 21, 71, 92, 105, 118, 120]. For the validation of
algorithms and TPSs these types of tests can be adopted from the existing
test packages [4, 105]. For quality audit purposes unspecific but sensitive
comprehensive tests with phantoms including curved surfaces and
inhomogeneities could be more practical [87, 106, 113].
Based on the results of this study [Publ. II] and the results of the reviewed
recent studies for TPSs for electron and photon beams the following
conclusions can be made: a) The accuracy level stated by Van Dyk et al.
[120] i.e. 3 to 4% (/ 4 mm) for photons and 5 to 7% (/ 5 mm) for electrons is
generally achieved by TPSs. b) The accuracy level stated by ICRU (2% / 2
mm) [46] can be achieved in simple geometries and occasionally in
geometries of curved surfaces and with inhomogeneities. The criteria of
ICRU can be considered objective for the accuracy of a TPS. c) Large
inaccuracies ( > 10%) are possible even with a modern TPS.
For epithermal neutron beams used in BNCT intercomparisons of TPSs
have not been performed, mainly because of a small number of systems
available. For the validation of an MC based TPS Zamenhof et al. performed
a test in a head phantom [125]. They detected an approximately 10 to 15%
consistency between the measured and calculated relative neutron dose
rates and a 5 to 6% consistency for the gamma dose rates [125]. Using a
semi-empirical calculation algorithms, Raaijmakers et al. found a 2%
consistency between the measured and calculated relative thermal neutron
fluences and a 5% consistency for gamma ray doses in a solid head phantom
[94]. Also up to 30% deviations for the calculated thermal neutron fluences
were found close to the air boundaries [94]. In this study the consistency of
the measured and calculated doses was 5 to 6% for gamma radiation and
18% for neutron radiation [Publ. V]. In all the studies mentioned for
epithermal neutron beams the uncertainties of doses (1sd) are at the same
level as the consistency of measurements and calculations.
In the verification of the performance of a modern TPS, either in electron
and photon radiotherapy or in BNCT the statement of  J.R. Cunningham
[22] is still in a great validity: “All calculation procedures must be tested by
comparison with carefully carried out experiments. The importance of
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experimental testing, preferably by the creator of the calculation method,
cannot be overestimated. Although several calculation procedures are
available, being approximate, they must be expected to have limitations and
it must be realized that there will be irradiation conditions that will fool
them”.
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7  SUMMARY
In electron beam dosimetry, the accuracy of dose determinations can be
improved remarkably through the direct calibrations of plane parallel
ionization chambers in high energy electron beams. These calibrations can
be performed fluently by an SSDL during periodic site visits to a clinic. In
photon beam dosimetry, the accuracy of dose determinations can be
improved by using the percentage dose at the 10 cm depth, %dd(10), as a
beam quality specifier. To quantify the final improvement of the accuracy in
photon dosimetry, the experiences of the users of %dd(10) and the results of
the comparative dose measurements using different beam specifiers are to
be waited. For electron and photon beam reference dosimetry, the results of
this study have been adopted in international Codes of Practices for
dosimetry.
In dosimetry of epithermal neutron beams a reasonable accuracy in the
determination of  gamma and neutron doses by ionization chambers was
achieved. To raise the accuracy close to the level achieved in electron and
photon beam dosimetry, improvements in tissue equivalent chamber
materials and calibration methods in neutron beams should be seeked and
used. For dosimetry of epithermal neutron beams in boron neutron capture
therapy (BNCT) the work towards coherent dosimetric methods has been
started under the European program. The results of this study are available
for this program and for the forthcoming Code of Practice in BNCT
dosimetry in Europe.
In dose calculations by treatment planning systems for electron and photon
beams, the development of dose calculation algorithms has not diminished
the value of experimental dose verification. Discrepancies of calculated
doses can be expected also for modern treatment planning systems and
comparative studies shall be performed. In BNCT the value of
intercomparisons is emphasized because of the unique, individual beam
facilities and a variety of dosimetry methods used. Furthermore, the
relatively large uncertainties of the measured doses in epithermal neutron
beams in BNCT broaden the limits of consistency between individual clinics.
For the quality assurance of a treatment planning system in BNCT the
similar validation procedures as used for electron and photon beams should
be performed.
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